Intraperitoneal chemotherapy as first-line treatment of newly diagnosed advanced epithelial ovarian cancer: Two centers' data in China

被引：0
|
作者：
Xie, X. [1 ]
Shen, Y. [1 ]
Tang, S. [1 ]
Cheng, X. [1 ]
Lv, W. [1 ]
Wan, X. [1 ]
Chen, Z. [2 ]
机构：
[1] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.649
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
761
引用
收藏
页码：348 / 348
页数：1
相关论文
共 50 条
  • [21] ADDITIONAL INTRAPERITONEAL CISPLATIN/ETOPOSIDE TO FIRST-LINE CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN CANCER: THEINTERIM ANALYSISOF A RANDOMIZED PHASE II STUDY
    Zang, R. Y.
    Yu, J. J.
    Dai, Z. Y.
    Jiang, R.
    Zhang, Y. Q.
    Wang, H. Y.
    Tang, J.
    Cheng, X.
    Cai, S. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [22] ADDITIONAL INTRAPERITONEAL CISPLATIN/ETOPOSIDE TO FIRST-LINE CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN CANCER: The PRELIMINARY ANALYSIS OF A RANDOMIZED PHASE II STUDY
    Jiang, R.
    Yu, J.
    Dai, Z.
    Shen, Y.
    Zhang, Y.
    Tu, R.
    Wang, H.
    Tang, J.
    Yang, H.
    Cheng, X.
    Tu, D.
    Jia, H.
    Cai, S.
    Zang, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 736 - 736
  • [23] Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer
    Papadimitriou, CA
    Kouroussis, C
    Moulopoulos, LA
    Vlahos, G
    Rodolakis, A
    Kiamouris, C
    Diakomanolis, E
    Gika, D
    Michalas, S
    Dimopoulos, MA
    CANCER, 2001, 92 (07) : 1856 - 1863
  • [24] Bevacizumab in the First-line Treatment of advanced Ovarian Cancer
    Mallmann, Michael R.
    Alakus, Hakan
    Mallmann, Peter
    Bruns, Christiane
    ONKOLOGE, 2019, 25 (11): : 1020 - 1021
  • [25] Combination of CPT-11 with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: Report of two cases
    Sugiyama, T
    Yakushiji, M
    Nishida, T
    ONCOLOGY REPORTS, 1997, 4 (02) : 345 - 348
  • [26] Intraperitoneal chemotherapy in advanced epithelial ovarian cancer: a survey
    Giuseppe Grosso
    Diego Rossetti
    Federico Coccolini
    Giorgio Bogani
    Luca Ansaloni
    Luigi Frigerio
    Archives of Gynecology and Obstetrics, 2014, 290 : 425 - 434
  • [27] Intraperitoneal chemotherapy in advanced epithelial ovarian cancer: a survey
    Grosso, Giuseppe
    Rossetti, Diego
    Coccolini, Federico
    Bogani, Giorgio
    Ansaloni, Luca
    Frigerio, Luigi
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (03) : 425 - 434
  • [28] Feasibility of intraperitoneal chemotherapy in advanced epithelial ovarian cancer
    Maheshwari, A.
    Gupta, S.
    Prabhash, K.
    Tongaonkar, H. B.
    INDIAN JOURNAL OF CANCER, 2010, 47 (02) : 225 - 226
  • [29] Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma A Feasibility Study
    D'Hondt, Veronique
    Goffin, Frederic
    Roca, Lise
    Dresse, Damien
    Leroy, Chantal
    Kerger, Joseph
    Cordier, Lionel
    de Forges, Helene
    Veys, Isabelle
    Liberale, Gabriel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (05) : 912 - 917
  • [30] Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial
    Tingyan Shi
    Rong Jiang
    Jinjin Yu
    Huijuan Yang
    Dongsheng Tu
    Zhiyuan Dai
    Yang Shen
    Yuqin Zhang
    Xi Cheng
    Huixun Jia
    Ruiqin Tu
    Huaying Wang
    Jie Tang
    Yuting Luan
    Shumo Cai
    Rongyu Zang
    British Journal of Cancer, 2018, 119 : 12 - 18
12345